NeuroStar Advanced TMS therapy is an outpatient treatment that takes as little as 19 minutes per session. A study of real-world outcomes reported an 83% response rate which means patients experienced notable relief, and a 62% remission rate which means their depression effectively went away.

The STAR*D study, the largest clinical trial of MDD ever conducted, showed that the rate of remission goes down with each new medication needed. If you’ve tried 3 or more medications, the chance of remission was just 7%.

NeuroStar is being used in over 1,100 practices nationwide.

TMS is Transcranial Magnetic Stimulation therapy, a non-drug treatment for major depression. TMS uses focused magnetic pulses, similar to an MRI, to reignite dormant synapses in the brain and help your brain function the way it was meant to.

It is not a drug, “shock” therapy, or surgery. It is a safe, effective treatment for MDD without the common side effects of medication.

Medical treatments for depression are usually centered around antidepressants that rely on the systems in your body to deliver relief. NeuroStar Advanced TMS treatments go right to the source of depression—your brain.

There are specific areas in your brain that control mood. When synapses in those mood-regulating areas are underactive, connections are broken and depression can result. NeuroStar revitalizes those dormant synapses, “waking up” the brain to function as it was meant to.

Many NeuroStar patients start to see improvement within 2 to 3 weeks of treatment. That can include changes in mood, fewer days of depression, and increased desire to engage with other people more often. In fact, your friends and family may notice your results before you do!

Completing the full NeuroStar treatment course gives the best chance for delivering long-lasting relief from depression.

As with any therapy, completion is key. Completing the full 6-week course of NeuroStar treatment gives the best chance for delivering long lasting relief from depression.

NeuroStar is the #1 physician recommended TMS treatment and has been proven safe and effective for patients who have not seen symptom improvement or remission from medications. If you have been diagnosed with MDD, and have not found relief from antidepressants, NeuroStar may be right for you.

The largest prospective clinical trial of major depressive disorder ever conducted, the STAR*D study showed that a patient’s chance for remission decreases with each subsequent medication attempt.

STAR*D also showed that the discontinuation of antidepressants due to side effects increases with each medication attempt.